Shareholders' Equity

6 Months Ended

Dec. 31, 2021

Stockholders' Equity Note [Abstract]

SHAREHOLDERS’ EQUITY

NOTE 5: - SHAREHOLDERS’ EQUITY

Pursuant to a shelf registration on Form S-3 declared effective by the SEC on July 23, 2020, in July 2020 the Company entered into an Open Market Sale Agreement (“ATM Agreement”) with Jefferies LLC (“Jefferies”), which provides that, upon the terms and subject to the conditions and limitations in the ATM Agreement, the Company may elect, from time to time, to offer and sell common shares having an aggregate offering price of up to $75,000 through Jefferies acting as sales agent. During the year ended June 30, 2021, the Company sold 1,045,097 common shares under the ATM Agreement at an average price of $8.50 per share for aggregate net proceeds of approximately $8,506, net of issuance expenses of $380. There were no sales under the ATM Agreement during the six months ended December 31, 2021.

a. Options to consultants:

A summary of the options to non-employee consultants under the Company’s 2005 and 2016 equity incentive plans is as follows:

	Six months ended December 31, 2021
	Number			Weighted Average Exercise  Price		Weighted  Average Remaining Contractual Terms (in years)		Aggregate Intrinsic Value Price
Options outstanding at the beginning of the period		39,836		$	-		6.99	$	158
Options granted		40,000		$	2.33
Options forfeited		(1,291	)	$	-
Options outstanding at the end of the period		78,545		$	1.19		8.33	$	56
Options exercisable at the end of the period		36,045		$	-		6.68	$	53
Options unvested		42,500		$	2.19
Options vested and expected to vest		78,545		$	1.19		8.33	$	56

Compensation expenses recorded in general and administration expenses related to options granted to consultants for the six and three months ended December 31, 2021 and 2020 were $10 and $6, $8 and $3, respectfully.

b. Restricted Shares units (“RSUs”) to employees, directors and consultants:

1. RSUs to employees and directors:

The following table summarizes the activity related to RSUs granted to employees and directors under the Company’s 2005, 2016 and 2019 equity incentive plans for the six-month period ended December 31, 2021:

	Six months ended December 31,
	2021			2020
	Number
Unvested at the beginning of the period		2,404,415			415,194
Granted		75,000			2,600,120
Forfeited		(32,480	)		(5,649	)
Vested		(233,570	)		(161,268	)
Unvested at the end of the period		2,213,365			2,848,397
Expected to vest after the end of the period		2,172,615			2,800,315

Compensation expenses related to RSUs granted to employees and directors were recorded as follows:

	Six months ended December 31,				Three months ended December 31,
	2021		2020		2021		2020
Research and development expenses	$	418	$	564	$	209	$	472
General and administrative expenses		4,494		4,168		1,587		3,346
	$	4,912	$	4,732	$	1,796	$	3,818

Unamortized compensation expenses related to RSUs granted to employees and directors is approximately $9,420 to be recognized by the end of December 2025.

2. RSUs to consultants:

The following table summarizes the activity related to unvested RSUs granted to consultants under the Company’s 2005, 2016 and 2019 equity incentive plans for the six-month period ended December 31, 2021 and 2020:

	Six months ended December 31,
	2021			2020
	Number
Unvested at the beginning of the period		76,249			6,250
Granted		-			110,000
Forfeited		-			(25,000	)
Vested		(33,750	)		(1,250	)
Unvested at the end of the period		42,499			90,000

Compensation expenses related to RSUs granted to consultants were recorded as follows:

	Six months ended December 31,				Three months ended December 31,
	2021		2020		2021		2020
Research and development expenses	$	45	$	68	$	13	$	(35	)
General and administrative expenses		94		51		56		35
	$	139	$	119	$	69	$	-